Survival adjusting for crossover: phase 3 study of ibrutinib vs. chlorambucil in older patients with untreated chronic lymphocytic leukemia/small lymphocytic lymphoma.

ABSTRACT:

SUBMITTER: Coutre S 

PROVIDER: S-EPMC6058772 | biostudies-literature | 2018 Jun

REPOSITORIES: biostudies-literature